北京市春立正达医疗器械股份有限公司（春立医疗，01858）于2026年3月4日公布了截至2026年2月28日的股份变动月报。报告显示，公司报告期内各类股份数量及注册股本维持不变。
根据公告，截至2月末，公司法定注册股本总额为人民币383,568,500元。其中，H股注册股本为人民币95,140,500元，A股注册股本为人民币288,428,000元；本期均无新增发行或注销情况，H股和A股数量分别保持在95,140,500股和288,428,000股。报告期内，公司亦未发生股份购回或库存股变动。
公司确认已满足香港联交所关于公众持股量的要求，并表示其所有证券发行、出售或转让均在法律及相关监管规定下进行。该公告由公司秘书叶沛森签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.